Anika Therapeutics, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ANIK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

52,994

Value ($000)

509

Weight

0.0%

2019 Q4 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	509	0.0%	52,994	12/31/2025
2025 Q3	11/13/2025	498	0.0%	52,994	9/30/2025
2025 Q2	8/13/2025	561	0.0%	52,994	6/30/2025
2025 Q1	5/14/2025	881	0.0%	58,595	3/31/2025
2024 Q4	2/12/2025	979	0.0%	59,455	12/31/2024
2024 Q3	11/14/2024	2,687	0.0%	108,793	9/30/2024
2024 Q2	8/14/2024	2,756	0.0%	108,793	6/30/2024
2024 Q1	5/15/2024	3,043	0.0%	119,819	3/31/2024
2023 Q4	2/14/2024	5,042	0.0%	222,510	12/31/2023
2023 Q3	11/14/2023	2,592	0.0%	139,114	9/30/2023
2021 Q4	2/14/2022	1,072	0.0%	29,906	12/31/2021
2021 Q3	11/12/2021	1,264	0.0%	29,696	9/30/2021
2021 Q2	8/13/2021	2,167	0.0%	50,061	6/30/2021
2020 Q2	8/12/2020	1,779	0.0%	47,155	6/30/2020
2020 Q1	5/15/2020	2,255	0.0%	77,990	3/31/2020
2019 Q4	2/13/2020	10,736	0.0%	207,060	12/31/2019